What is the most recent earnings date for TARO stock?
TARO PHARMACEUTICAL INDUS (TARO) last reported earnings on 5/20/2024.
TARO PHARMACEUTICAL INDUS (TARO) Earnings History & Surprises
NYSE:TARO • IL0010827181
Current stock price
42.97 USD
0 (0%)
At close:
42.97 USD
0 (0%)
After Hours:
TARO Earnings overview
Past quarterly earnings results for TARO PHARMACEUTICAL INDUS (TARO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Jul 24, 2024
Last Reported
Most Recent- Release Date
- May 20, 2024
- Period
- Q4 / 2024
- EPS Reported
- $0.40
- EPS Surprise
- 26.50%
- Revenue Surprise
- 3.62%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2024 | 0.40 | 0.32 | 26.50% | -25.93% | 164.941M | 159.18M | 3.62% | 4.96% |
| Q3 2024 | 0.54 | 0.31 | 76.47% | 184.21% | 157.145M | 158.01M | -0.55% | 12.89% |
| Q2 2024 | 0.38 | 0.18 | 106.97% | 642.86% | 148.202M | 164.36M | -9.83% | 13.56% |
| Q1 2024 | 0.40 | 0.32 | 26.50% | 8.11% | 164.941M | 159.18M | 3.62% | 5.26% |
| Q4 2023 | 0.54 | 0.31 | 76.47% | -26.03% | 157.145M | 158.01M | -0.55% | 9.66% |
| Q3 2023 | 0.19 | 0.89 | -78.59% | -72.86% | 139.2M | 166.38M | -16.34% | 0.14% |
| Q2 2023 | -0.07 | 0.86 | -108.17% | -110.61% | 130.5M | 164.24M | -20.54% | -1.14% |
| Q1 2023 | 0.37 | 0.87 | -57.32% | -66.06% | 156.7M | 152.87M | 2.51% | 6.53% |
| Q4 2022 | 0.73 | 0.90 | -18.67% | 193.59% | 143.3M | 149.95M | -4.43% | -3.37% |
| Q3 2022 | 0.70 | 0.93 | -24.59% | -18.60% | 139M | 145.07M | -4.18% | -0.79% |
| Q2 2022 | 0.66 | 1.04 | -36.56% | -44.07% | 132M | 156.29M | -15.54% | -7.56% |
| Q1 2022 | 1.09 | 0.86 | 27.22% | 109.59% | 147.1M | 139.97M | 5.09% | 25.09% |
| Q4 2021 | -0.78 | 0.94 | -183.12% | -154.93% | 148.3M | 150.27M | -1.31% | -15.21% |
| Q3 2021 | 0.86 | 1.03 | -16.52% | -51.14% | 140.1M | 155.69M | -10.01% | -5.15% |
| Q2 2021 | 1.18 | 0.79 | 50.24% | -19.18% | 142.8M | 127.85M | 11.69% | -11.25% |
| Q1 2021 | -11.37 | 1.18 | -1,060.95% | -761.05% | 117.6M | 161.52M | -27.19% | -27.09% |
| Q4 2020 | 1.42 | 1.56 | -9.01% | - | 174.9M | 171.61M | 1.92% | - |
| Q3 2020 | 1.76 | 1.57 | 12.04% | - | 147.7M | 175.45M | -15.82% | - |
| Q2 2020 | 1.46 | 1.75 | -16.78% | - | 160.9M | 171.93M | -6.42% | - |
| Q1 2020 | 1.72 | 2.00 | -13.97% | - | 161.3M | 173.2M | -6.87% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
59.11%
Max EPS beat (4)
106.97%
Min EPS beat (4)
26.50%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-0.56%
Max Revenue beat (4)
4.53%
Min Revenue beat (4)
-9.83%
Analysis
In the last 4 quarters, TARO has consistently beaten EPS estimates in all releases
TARO has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, TARO has beaten the EPS estimates by 59.1% on average.
In the last 4 quarters, TARO reported -0.6% below the revenue estimates on average.
Related analysis
TARO PHARMACEUTICAL INDUS / TARO Earnings FAQ
Did TARO stock beat earnings estimates in the most recent quarter?
TARO PHARMACEUTICAL INDUS (TARO) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often TARO PHARMACEUTICAL INDUS beats earnings estimates?
In the last 4 quarters, TARO PHARMACEUTICAL INDUS (TARO) has beaten EPS estimates in 4 out of 4 releases.